Multiple primary malignant neoplasms (MPMN) represent the occurrence of a second malignancy in the same patient within 6 months after the detection of first primary (synchronous) tumor, or > 6 months after primary detection (metachronous). We present a case of a patient treated for carcinoma of the breast who developed a metachronous primary malignancy in the colorectal tract. These tumors were histologically different with distinct immune-histochemical parameters. The association between breast and colon cancer is well documented in the literature with several studies reporting the coexistence of common extrinsic and genetic predisposing factors. Although rare, MPMN are becoming more common due to the increased number of elder...
Individuals diagnosed with colorectal cancer (CRC) are at risk of developing a metachronous CRC. We ...
Introduction: While colorectal carcinoma is one of the most commonly diagnosed malignancies, its syn...
The incidence of secondary primary malignancy (SPM) has been reported to range from 1.33% to 5.8%, a...
Any two or more primary malignant tumors, in which each tumor is not an extension, recurrence, or me...
Multiple primary tumors occur in clinical practice causing diagnostic dilemma. It is not very common...
Multiple primary tumors occur in clinical practice causing diagnostic dilemma. It is not very common...
A 65-year-old female patient presented to the emergency clinic with abdominal pain, meteorism, and i...
Multiple primary cancers, although uncommon, have been increasing in incidence in recent years. This...
A 70-year-old female patient with prior breast cancer was diagnosed with colorectal carcinoma six ye...
Multiple primary cancer is an incidence when a patient has multiple malignancy in two or more organs...
cancer and lymphoma. Am J Epidemiol 104:517-522. 1976. Four patients are presented who were ascertai...
Purpose: With advance in diagnostic techniques and treatment modalities, it has been increasing that...
Multiple primary neoplasms (MPNs) comprise synchronous or metachronous tumors. They arise after diag...
Most cancer patients often neglect the possibility of secondary cancer. Colorectal cancer (CRC) is t...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Individuals diagnosed with colorectal cancer (CRC) are at risk of developing a metachronous CRC. We ...
Introduction: While colorectal carcinoma is one of the most commonly diagnosed malignancies, its syn...
The incidence of secondary primary malignancy (SPM) has been reported to range from 1.33% to 5.8%, a...
Any two or more primary malignant tumors, in which each tumor is not an extension, recurrence, or me...
Multiple primary tumors occur in clinical practice causing diagnostic dilemma. It is not very common...
Multiple primary tumors occur in clinical practice causing diagnostic dilemma. It is not very common...
A 65-year-old female patient presented to the emergency clinic with abdominal pain, meteorism, and i...
Multiple primary cancers, although uncommon, have been increasing in incidence in recent years. This...
A 70-year-old female patient with prior breast cancer was diagnosed with colorectal carcinoma six ye...
Multiple primary cancer is an incidence when a patient has multiple malignancy in two or more organs...
cancer and lymphoma. Am J Epidemiol 104:517-522. 1976. Four patients are presented who were ascertai...
Purpose: With advance in diagnostic techniques and treatment modalities, it has been increasing that...
Multiple primary neoplasms (MPNs) comprise synchronous or metachronous tumors. They arise after diag...
Most cancer patients often neglect the possibility of secondary cancer. Colorectal cancer (CRC) is t...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Individuals diagnosed with colorectal cancer (CRC) are at risk of developing a metachronous CRC. We ...
Introduction: While colorectal carcinoma is one of the most commonly diagnosed malignancies, its syn...
The incidence of secondary primary malignancy (SPM) has been reported to range from 1.33% to 5.8%, a...